Molecular Formula | C17H29N3O6S |
Molar Mass | 403.49 |
Density | 1.234±0.06 g/cm3(Predicted) |
Boling Point | 752.2±60.0 °C(Predicted) |
pKa | 4.28±0.10(Predicted) |
Storage Condition | Room Temprature |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
bioactivity | Biotin-PEG2-acid is a non-degradable ADC linker containing 2 units of PEG, it can be used to synthesize antibody-conjugated drugs (ADCS). Biotin-PEG2-acid is a PROTAC linker, belonging to the PEG class, which can be used to synthesize PROTAC molecules. |
Target | PEGs Non-cleavable |
in vitro study | ADCs are combined of an antibody to which is attached an ADC cytoxin through an ADC linker. PROTACs contains two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intrinsic ubiquitin-proteasome system to selective grade target proteins. |